Advance Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Advance Pharmaceutical Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011833
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advance Pharmaceutical Co Ltd (APC), formerly Dang Ling is a healthcare products provider that manufactures and distributes prescription and over the counter pharmaceutical products. The company’s products include vitamins and supplements, cough syrups, skin care, disinfectant liquids, and respiratory products. It also offers alcohol wet wipes, mouth rinse mint flavors, adult diapers, soaps, multi purpose kitchen cleaner, hand wash lotions, hand wash lotions, and glycerin, among others. APC conducts research and development for the manufacturing, design, marketing, sales, logistics and distribution. The company provides products for various diseases such as cold and flu, analgesic and antipyretic, indigestion, respiratory, and dermatological. It markets products to local dispensaries, medicine shops, clinics, hospitals and chain stores. APC is headquartered in Hong Kong.

Advance Pharmaceutical Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Boston Therapeutics Expands Licensing Agreement with Advance Pharma for SugarDown 10
Licensing Agreements 11
Boston Therapeutics Expands Licensing Agreement with Advance Pharma 11
Boston Therapeutics Enters Into Licensing Agreement With Advance Pharma For SUGARDOWN 12
Equity Offering 13
Boston Therapeutics Completes Private Placement Of Shares For US$0.5 Million 13
Advance Pharmaceutical Co Ltd – Key Competitors 14
Advance Pharmaceutical Co Ltd – Key Employees 15
Advance Pharmaceutical Co Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advance Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Advance Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Boston Therapeutics Expands Licensing Agreement with Advance Pharma for SugarDown 10
Boston Therapeutics Expands Licensing Agreement with Advance Pharma 11
Boston Therapeutics Enters Into Licensing Agreement With Advance Pharma For SUGARDOWN 12
Boston Therapeutics Completes Private Placement Of Shares For US$0.5 Million 13
Advance Pharmaceutical Co Ltd, Key Competitors 14
Advance Pharmaceutical Co Ltd, Key Employees 15

★海外企業調査レポート[Advance Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cancom SE (COK):企業の財務・戦略的SWOT分析
    Cancom SE (COK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • OncoMed Pharmaceuticals Inc (OMED):企業のM&A・提携動向(医療分野)
    Summary OncoMed Pharmaceuticals Inc (OncoMed) which focuses on the discovery and development of monoclonal antibody therapeutics that targets cancer stem cells. The company's clinical stage pipeline product candidate includes demcizumab, tarextumab, vantictumab, ipafricept, anti-RSPO3, brontictuzuma …
  • Sutro Biopharma, Inc.(製薬・医療分野):企業M&A動向
    Summary Sutro Biopharma, Inc. (Sutro) is a biopharmaceutical company. The company develops multi-functional antibody drug conjugate combination therapeutics and bifunctional antibody-based therapeutics for cancer therapies. Its biochemical synthesis technology allows the systematic exploration of pr …
  • Union Insurance Company P.S.C. (UNION):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Union Insurance Company P.S.C." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric str …
  • Polyplex Corporation Limited (POLYPLEX):企業の財務及び戦略的SWOT分析
    Summary Polyplex Corporation Limited (PCL) is a chemical company that manufactures thin polyester film in a wide range of thickness and surface properties. The company also offers BOPP film and CPP film. It offers a wide range of plastic film across several substrates such as sarafil, saracote, sara …
  • Datamatics Global Services Limited (DATAMATICS):企業の財務及び戦略的SWOT分析
    Summary Datamatics Global Services Limited (Datamatics) is an information technology company that provides software solutions. The company offers products such as application management, application testing, billing and statement generation, finance and accounting, analytics solutions and smart docu …
  • Computer Engineering & Consulting, Ltd. (9692):企業財務及び戦略的SWOT分析
    Summary Computer Engineering & Consulting, Ltd. (CEC) is a technology company that provides IT management services. The company offers industry automation, assisting in realizing a factory by providing services; system integration, assisting in accelerating business by providing a sophisticated solu …
  • Airbus Helicopters(航空・防衛):企業概要、SWOT分析
    Summary SDI's "Airbus Helicopters: Aerospace and Defense - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company histo …
  • Bioasis Technologies Inc. (BTI):企業のM&A・提携動向(医療機器分野)
    Summary Bioasis Technologies Inc. (BTI) is a biopharmaceutical company that offers pharmaceutical products. The company develops and commercializes pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. Its transcend program describes the proprietary c …
  • Tiscali SpA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tiscali SpA Mergers and Acquisi …
  • Mitsubishi International Food Ingredients, Inc.:企業の戦略・SWOT・財務分析
    SummaryMitsubishi International Food Ingredients, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ …
  • Husqvarna AB:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Husqvarna AB Mergers and Acquis …
  • Tokai Electronics, Co., Ltd. (8071):企業財務及び戦略的SWOT分析
    Summary Tokai Electronics, Co., Ltd. (Tokai Electronics) formerly Tokai Bussan, Co., Ltd., is an information technology company that develops, sells, imports and exports electronic devices, semiconductor devices and high-performance materials. The company’s products include material devices, electro …
  • Nippon Shikizai Inc.:企業の戦略・SWOT・財務分析
    SummaryNippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Fi …
  • A.P. Moller-Maersk A/S:企業の戦略・SWOT・財務分析
    SummaryA.P. Moller-Maersk A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Oil and Natural Gas Corporation Limited (ONGC):企業のM&A・提携動向(発電分野)
    Summary Oil and Natural Gas Corporation Limited (ONGC) is an integrated oil and gas company. It carries out exploration, production, refining and transportation oil and natural gas in India and abroad. The company's product portfolio includes crude oil natural gas, liquefied natural gas, aviation tu …
  • Elizabeth Arden, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Elizabeth Arden, Inc. Mergers a …
  • Galena Biopharma, Inc. (GALE):企業のM&A・提携動向(医療機器分野)
    Summary Galena Biopharma, Inc. (Galena) is a biotechnology company that discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. The company’s products portfolio include Abstral, used for in management of acute or postoperative pain, including head …
  • Amdipharm plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Amdipharm plc Mergers and Acqui …
  • Airborne Tactical Advantage Company:企業の戦略・SWOT・財務分析
    SummaryAirborne Tactical Advantage Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆